|Company name||Cavco Industries, Inc.|
NEW YORK, February 7, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against Natus Medical Incorporated (NASDAQ: BABY). Our investigation concerns whether Natus has violated the federal securities laws and/or engaged in other unlawful business practices.
On February 6, 2019, GlassHouse Research published a report entitled “Throw the BABY (Natus Medical Inc.) Out with the Bathwater,” accusing the company of deceptive accounting practices. On this news, Natus’ share price fell by more than 4%, closing at $31.50 on February 6, 2019.
If you purchased or otherwise acquired Natus shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.